Clinical Trials Logo
  1. Home
  2. Penicillin Allergy
  3. NCT03499457
  4. Details
NCT03499457 Clinical Trial

Penicillin Allergy in Shfayim Clinic

Penicillin Allergy Clinical Trial

Official title:
Penicillin Allergy in Shfayim Clinic

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03499457
Other study ID # 0185-17-COM2
Secondary ID
Status Not yet recruiting
Phase N/A
First received April 8, 2018
Last updated April 8, 2018
Start date June 2018
Est. completion date June 2019

Study information
Verified date April 2018
Source Clalit Health Services
Contact lital f goldberg, MD. MPH.
Phone 972544248284
Email litalmargalith@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

revising penicillin allergy in the medical records, by taking full medical history and giving a challange test, in order to imrove the medical records and treatment possibilities.

Description:

issuing a list of patients with a title of penicillin allergy in their medical record. inviting these patients to an appointmnet with their family physician, in which a specific history will be take to evaluate the quality of the allergy.

patients with suscpition of a life threatening allergic reaction will be reffered to an allergy clinic for the challange test. the rest of the pateints will be given the test in the primary clinic: 1ml (50 grams) of amoxicillin, and an hour later a full dose of 500 mg amoxicillin.

after determining no allergic reaction develops the title will be erased from the medical record.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 100
Est. completion date June 2019
Est. primary completion date January 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 80 Years
Eligibility Inclusion Criteria:

penicillin allergy in the medical record

Exclusion Criteria:

pregnancy lack of informed consent

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Amoxicillin
chalange test of 50 mg, and after an hour 500 mg

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Clalit Health Services

Outcome
Type Measure Description Time frame Safety issue
Primary immidiate urticarial reaction shortness of breath, angioedema with 2 hours of test
Secondary rash body rash or itch seen by patient or physician with 2 hours of test
See also
  Status Clinical Trial Phase
Terminated NCT05563610 - Oral Penicillin Challenge and Allergy De-labeling in Children Phase 4
Completed NCT05020327 - Inpatient Penicillin Allergy Delabeling Study Phase 4
Completed NCT04441021 - Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy
Not yet recruiting NCT05956080 - Penicillin Allergy Delabeling Among Surgical Patients N/A
Recruiting NCT03757052 - Amoxicillin Challenge for Penicillin Allergy Diagnosis N/A
Completed NCT03702270 - The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal N/A
Recruiting NCT05464615 - Geisinger Antibiotic Allergy Pilot Program: Assess and Address Early Phase 1
Completed NCT03702283 - Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting N/A
Completed NCT01667055 - The Diagnosis of Beta-lactam Hypersensitivity in Thailand
Withdrawn NCT00589251 - Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique N/A
Completed NCT04620746 - Penicillin Allergy Testing in STD Clinics Phase 4
Completed NCT05090527 - Penicillin Allergy Delabeling Project N/A
Completed NCT03033394 - Beta-lactam Pharmacokinetics in Secondary Care
Completed NCT02036840 - Perioperative Antibiotic Choices for Surgical Prophylaxis in Penicillin-allergic Pediatric Patients N/A
Terminated NCT00363688 - Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin Phase 4
Completed NCT03158831 - Drug Challenges Without Prior Skin Testing Phase 1
Recruiting NCT06303128 - Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge Phase 3
Completed NCT03942731 - Penicillin Allergy Testing and Resensitization Rate
Completed NCT05010304 - Penicillin De-labeling in the Pediatric Primary Care Setting Phase 4
Completed NCT03404804 - Oral Challenge in the Pediatric ED Phase 4